SK280815B6 - Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii - Google Patents
Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii Download PDFInfo
- Publication number
- SK280815B6 SK280815B6 SK1170-95A SK117095A SK280815B6 SK 280815 B6 SK280815 B6 SK 280815B6 SK 117095 A SK117095 A SK 117095A SK 280815 B6 SK280815 B6 SK 280815B6
- Authority
- SK
- Slovakia
- Prior art keywords
- hydrogen
- cells
- thia
- diazabicyclo
- octane
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 13
- 238000002560 therapeutic procedure Methods 0.000 title description 2
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 9
- 239000001257 hydrogen Substances 0.000 claims abstract description 9
- 150000002431 hydrogen Chemical group 0.000 claims abstract description 8
- 229910052736 halogen Chemical group 0.000 claims abstract description 6
- 150000002367 halogens Chemical group 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 3
- 210000004027 cell Anatomy 0.000 claims description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 210000004881 tumor cell Anatomy 0.000 claims description 4
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 2
- 125000005544 phthalimido group Chemical group 0.000 claims description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims 2
- 239000012894 fetal calf serum Substances 0.000 claims 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims 1
- 229930182555 Penicillin Natural products 0.000 claims 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940049954 penicillin Drugs 0.000 claims 1
- 229960005322 streptomycin Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
- 230000004614 tumor growth Effects 0.000 claims 1
- 230000001629 suppression Effects 0.000 abstract description 3
- 208000019065 cervical carcinoma Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 238000011319 anticancer therapy Methods 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR940577A HRP940577B1 (en) | 1994-09-21 | 1994-09-21 | Use of 5-thia-1,4-diazabicyclo (4.2.0) octane-3,8-dioxo compounds in antitumor therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK117095A3 SK117095A3 (en) | 1996-09-04 |
| SK280815B6 true SK280815B6 (sk) | 2000-08-14 |
Family
ID=10946157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1170-95A SK280815B6 (sk) | 1994-09-21 | 1995-09-21 | Použitie 5-tia-1,4-diazabicyklo[4.2.0]oktán-3,8-dioxozlúčeniny v protinádorovej terapii |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0705606B1 (de) |
| JP (1) | JPH08310954A (de) |
| CN (1) | CN1127115A (de) |
| AT (1) | ATE164069T1 (de) |
| BG (1) | BG62237B1 (de) |
| CA (1) | CA2158678C (de) |
| CZ (1) | CZ285621B6 (de) |
| DE (1) | DE69501810T2 (de) |
| ES (1) | ES2115303T3 (de) |
| HR (1) | HRP940577B1 (de) |
| HU (1) | HU218287B (de) |
| RU (1) | RU2136284C1 (de) |
| SI (1) | SI9500297A (de) |
| SK (1) | SK280815B6 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101671336B (zh) * | 2009-09-23 | 2013-11-13 | 辽宁利锋科技开发有限公司 | 芳杂环并嘧啶衍生物和类似物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598188A (en) * | 1979-01-23 | 1980-07-25 | Mitsui Toatsu Chem Inc | Novel cephalosporin and its preparation |
| JPS57171994A (en) * | 1981-04-15 | 1982-10-22 | Asahi Chem Ind Co Ltd | Novel compound |
| HRP921292A2 (en) | 1992-11-17 | 1994-08-31 | Pliva Pharm & Chem Works | 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof |
-
1994
- 1994-09-21 HR HR940577A patent/HRP940577B1/xx not_active IP Right Cessation
-
1995
- 1995-09-18 AT AT95114673T patent/ATE164069T1/de not_active IP Right Cessation
- 1995-09-18 ES ES95114673T patent/ES2115303T3/es not_active Expired - Lifetime
- 1995-09-18 EP EP95114673A patent/EP0705606B1/de not_active Expired - Lifetime
- 1995-09-18 DE DE69501810T patent/DE69501810T2/de not_active Expired - Fee Related
- 1995-09-20 CZ CZ952447A patent/CZ285621B6/cs not_active IP Right Cessation
- 1995-09-20 RU RU95116239A patent/RU2136284C1/ru active
- 1995-09-20 JP JP7241717A patent/JPH08310954A/ja active Pending
- 1995-09-20 CA CA002158678A patent/CA2158678C/en not_active Expired - Fee Related
- 1995-09-21 CN CN95116888A patent/CN1127115A/zh active Pending
- 1995-09-21 HU HU9502770A patent/HU218287B/hu not_active IP Right Cessation
- 1995-09-21 SI SI9500297A patent/SI9500297A/sl unknown
- 1995-09-21 SK SK1170-95A patent/SK280815B6/sk unknown
- 1995-09-21 BG BG100020A patent/BG62237B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1127115A (zh) | 1996-07-24 |
| RU2136284C1 (ru) | 1999-09-10 |
| HRP940577B1 (en) | 1998-12-31 |
| CA2158678A1 (en) | 1996-03-22 |
| BG62237B1 (bg) | 1999-06-30 |
| JPH08310954A (ja) | 1996-11-26 |
| HUT74422A (en) | 1996-12-30 |
| DE69501810D1 (de) | 1998-04-23 |
| CZ244795A3 (en) | 1996-04-17 |
| BG100020A (bg) | 1996-04-30 |
| ATE164069T1 (de) | 1998-04-15 |
| ES2115303T3 (es) | 1998-06-16 |
| CA2158678C (en) | 2000-04-18 |
| EP0705606A1 (de) | 1996-04-10 |
| HU9502770D0 (en) | 1995-11-28 |
| SI9500297A (en) | 1996-04-30 |
| DE69501810T2 (de) | 1998-09-24 |
| CZ285621B6 (cs) | 1999-10-13 |
| EP0705606B1 (de) | 1998-03-18 |
| HRP940577A2 (en) | 1997-04-30 |
| HU218287B (en) | 2000-07-28 |
| SK117095A3 (en) | 1996-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0621263A2 (de) | Entzündungshemmendes und analgetisches äusserliches Pflaster-Präparat | |
| EE05530B1 (et) | Gamma-aminov?ihappe derivaate sisaldavad tahked kompositsioonid ja nende saamise meetod | |
| BR0009083A (pt) | Derivado de amida, processo para a preparação de um derivado de amida, composição farmacêutica, uso de um derivado de amida, método de tratamento de doenças ou de condições médicas mediadas por citocinas | |
| BR0212346A (pt) | Composto ou um sal farmaceuticamente aceitável, solvato, solvato deste sal ou uma pró-droga do mesmo, processo para a preparação do mesmo, uso deste, método para produzir um efeito inibidor de ibat em um animal de sangue quente, como um humano, em necessidade deste tratamento, e, composição farmacêutica | |
| SK281214B6 (sk) | Perorálny kvapalný farmaceutický prostriedok, spôsob jeho výroby a jeho použitie | |
| ES2130247T3 (es) | Derivados amidino y su uso como inhibidores de la oxido nitrico sintasa. | |
| JPS5632463A (en) | Imidazole derivative* its manufacture and medicine as active component thereof | |
| KR19980703830A (ko) | 바이러스 및 암 성장 억제용, 엔-포스포노글리신 유도체 함유 약학 조성물 | |
| WO2001045712A1 (de) | Arzneimittelkombinationen gegen virale erkrankungen | |
| JPH09501653A (ja) | 薬学的組成物 | |
| ATE201671T1 (de) | Chinolon und acridinon derivate zur behandlung der harninkontinenz | |
| SK48299A3 (en) | Local anesthetic for external use | |
| ES8207124A1 (es) | Un procedimiento para la preparacion de derivados de aminas secundarias. | |
| JPS62270525A (ja) | 免疫病の処置のための医薬組成物 | |
| FI834800A0 (fi) | Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat | |
| SK117095A3 (en) | 5-thia-1,4-diazabicyclo£4.2.0|octane-3,8-dioxo-compounds | |
| KR100718030B1 (ko) | 변형성 관절증 치료제 | |
| DE3855824T2 (de) | Anti-Plasmin Depressant | |
| Benova et al. | Protection of the mouse from genetic radiation damage by an optimal-dose-ratio combination of ATP, AET, and serotonin | |
| ATE21908T1 (de) | Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| HRP940433A2 (en) | Use of 4-oxo-azetidin-2-sulfinic and 2-sulfonic acids and derivatives thereof in antitumor therapy | |
| NL8600480A (nl) | Gestabiliseerde injectiesamenstellingen en de bereiding ervan. | |
| JPH02240072A (ja) | フエニルピラジンの塩、その製法及び該塩を含有する中枢神経系作用剤並びに該医薬の製法 | |
| UA70455A (en) | Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage | |
| ITMI951252A1 (it) | Bicarbonati di derivati della 2,6-dimetilanilina loro uso in terapia e composizioni farmaceutiche che li comprendono |